Evidence map›Paper›PMID 41820564›Full record

ArticleNature metabolism2026

Defining the vascular niche of human adipose tissue across metabolic states.

Ibrahim AlZaim, Mohamed N Hassan, Maja Schröter, Luca Mannino, Katarina Dragicevic, Marie Balle Sjogaard, Joseph Festa, Lolita Dokshokova, Sophie Weinbrenner, Blanca Tardajos Ayllon and 33 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

43 authors.

Ibrahim AlZaim *Department of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0001-6677-4365
Mohamed N Hassan *Department of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-8358-4122
Maja SchröterDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0009-0003-0069-1761
Luca ManninoDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0009-0006-2549-2680
Katarina DragicevicDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-0214-9189
Marie Balle SjogaardDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0001-9166-2795
Joseph FestaDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Lolita DokshokovaDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Sophie WeinbrennerHelmholtz Institute for Metabolic Obesity and Vascular Research of the Helmholtz Zentrum München, University of Leipzig and University Hospital Leipzig, Leipzig, Germany.ORCID http://orcid.org/0009-0002-4719-9953
Blanca Tardajos AyllonCentre for Microvascular Research, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0001-6466-8366
Bettina HansenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Rikke Kongsgaard RasmussenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-3366-7931
Julie N ChristensenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Olivia WagmanDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Ruby SchipperDivision of Cardiovascular Medicine, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Min CaiDivision of Cardiovascular Medicine, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Wouter DheedeneDepartment of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0001-8798-0395
Anja Bille BohnDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Jean FarupDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-7579-6512
Lin LinDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-7546-4948
Samuele SoraggiBioinformatics Research Centre, Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.
Anna Dalsgaard ThorsenDepartment of Internal Medicine, Viborg Regional Hospital, Viborg, Denmark.
Amanda BækSteno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.ORCID http://orcid.org/0009-0005-1500-5466
Henrik Holm ThomsenDepartment of Internal Medicine, Viborg Regional Hospital, Viborg, Denmark.ORCID http://orcid.org/0000-0003-0522-0320
Maximilian von HeesenClinic for General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany.
Lena-Christin ConradiClinic for General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany.
Paul EvansCentre for Microvascular Research, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0001-7975-681X
Carolina E HagbergDivision of Cardiovascular Medicine, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-5497-2855
Joerg HeerenDepartment of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0002-5647-1034
Margo EmontDivision of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID http://orcid.org/0000-0001-9873-2784
Evan D RosenDivision of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Aernout LuttunDepartment of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0001-7902-9524
Anders EtzerodtDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-6757-2068
Lucas MassierHelmholtz Institute for Metabolic Obesity and Vascular Research of the Helmholtz Zentrum München, University of Leipzig and University Hospital Leipzig, Leipzig, Germany.ORCID http://orcid.org/0000-0002-6199-2643
Mikael RydénDepartment of Medicine Huddinge (H7), Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden.ORCID http://orcid.org/0000-0003-4785-1876
Niklas MejhertDepartment of Medicine Huddinge (H7), Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden.ORCID http://orcid.org/0000-0003-1785-833X
Matthias BlüherHelmholtz Institute for Metabolic Obesity and Vascular Research of the Helmholtz Zentrum München, University of Leipzig and University Hospital Leipzig, Leipzig, Germany.ORCID http://orcid.org/0000-0003-0208-2065
Konstantin KhodosevichBiotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-7232-5558
Robert A FentonDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0003-1623-199X
Bilal N SheikhHelmholtz Institute for Metabolic Obesity and Vascular Research of the Helmholtz Zentrum München, University of Leipzig and University Hospital Leipzig, Leipzig, Germany.
Niels JessenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0001-5613-7274
Laura P M H de RooijCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Joanna KaluckaDepartment of Biomedicine, Aarhus University, Aarhus, Denmark. joanna.kalucka@biomed.au.dk.ORCID http://orcid.org/0000-0003-4887-7672

Funding

Investigating Human Adipocyte HeterogeneityRC2DK116691 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Orr Ashenberg, Noel P Burtt · 2018 to 2026
$17.8M
Carlsbergfondet (Carlsberg Foundation) CF19-0687Deutsche Forschungsgemeinschaft (German Research Foundation) SFB-Transregio 333, project-ID 450149205Karolinska Institutet (Karolinska Institute) 2020-00893Karolinska Institutet (Karolinska Institute) 2-189/2022KU Leuven (Katholieke Universiteit Leuven) C14/19/095Lundbeckfonden (Lundbeck Foundation) R307-2018-3667NIDDK NIH HHS RC2 DK116691Novo Nordisk Fonden (Novo Nordisk Foundation) NNF20OC0063268Novo Nordisk Fonden (Novo Nordisk Foundation) NNF21OC0067146Novo Nordisk Fonden (Novo Nordisk Foundation) NNF21OC0067647Novo Nordisk Fonden (Novo Nordisk Foundation) NNF21OC0071718Vetenskapsrådet (Swedish Research Council) 2019-02046
6 · The paper itself

Abstract

Adipose tissue homeostasis depends on an intact vascular network that ensures adequate nutrient delivery and immune regulation. In obesity, vascular dysfunction, particularly within endothelial cells (ECs), contributes to inflammation and metabolic disease progression, yet the cellular organization of the human adipose vasculature remains poorly defined. Here we show, using single-cell RNA sequencing of nearly 70,000 vascular cells from human subcutaneous adipose tissue of 65 individuals, that the adipose vasculature is highly heterogeneous and consists of seven canonical EC subtypes. In addition, we identify a distinct population of ECs that display mixed endothelial, mesenchymal, adipocytic and immune transcriptional features. Computational analyses and whole-mount imaging support their presence and suggest that they emerge through endothelial-to-mesenchymal transition. Comparative analyses further reveal inflammatory and fibrotic vascular signatures in obesity and type 2 diabetes. Together, this atlas delineates the cellular complexity of the human adipose vasculature and highlights its contribution to metabolic disease.

Indexed as

Adipose TissueDiabetes Mellitus, Type 2Endothelial CellsEndothelial-Mesenchymal TransitionHumansObesity

Identifiers

PMID41820564

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.